The clinical impact of bacterial co-infection among moderate, severe and critically ill COVID-19 patients in the second referral hospital in Surabaya [version 2; peer review: 2 approved]
Background: Data on the prevalence of bacterial co-infections among COVID-19 patients are limited, especially in our country, Indonesia. We aimed to assess the rate of bacterial co-infections in hospitalized COVID-19 patients and report the most common microorganisms involved and the antibiotic use...
Main Authors: | Tri Pudy Asmarawati, Alfian Nur Rosyid, Satriyo Dwi Suryantoro, Bagus Aulia Mahdi, Choirina Windradi, Prastuti Asta Wulaningrum, Muhammad Vitanata Arifianto, Bramantono Bramantono, Erwin Astha Triyono, Musofa Rusli, Brian Eka Rachman, Erika Marfiani, Pepy Dwi Endraswari, Usman Hadi, Kuntaman Kuntaman, Nasronudin Nasronudin |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2021-03-01
|
Series: | F1000Research |
Online Access: | https://f1000research.com/articles/10-113/v2 |
Similar Items
-
Duration of SARS-CoV-2 RNA Shedding Is Significantly Influenced by Disease Severity, Bilateral Pulmonary Infiltrates, Antibiotic Treatment, and Diabetic Status: Consideration for Isolation Period
by: Muhammad Vitanata Arfijanto, et al.
Published: (2023-05-01) -
Prolonged fever and exaggerated hypercoagulopathy in malaria vivax relapse and COVID-19 co-infection: a case report
by: Tri Pudy Asmarawati, et al.
Published: (2022-06-01) -
SUSCEPTIBILITY PATTERN OF METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS BACTERIA IN DR. SOETOMO GENERAL ACADEMIC HOSPITAL SURABAYA
by: Sacharissa Zerlina Tsarwah Thirafi, et al.
Published: (2022-10-01) -
Puzzling Clinical Appearance of a Pancreatic Tuberculosis Case
by: Anak Agung Fendy Tri Wicaksana, et al.
Published: (2023-07-01) -
Optimal use of tocilizumab for severe and critical COVID-19: a systematic review and meta-analysis [version 1; peer review: 1 approved, 2 approved with reservations]
by: Cahyo Wibisono Nugroho, et al.
Published: (2021-02-01)